Terms: = Bone cancer AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234 AND Prognosis
17 results:
1. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
Helbig G; Klion AD
Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
[TBL] [Abstract] [Full Text] [Related]
2. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
[TBL] [Abstract] [Full Text] [Related]
3. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract] [Full Text] [Related]
4. Imatinib for the treatment of hypereosinophilic syndromes.
Helbig G
Expert Rev Clin Immunol; 2018 Feb; 14(2):163-170. PubMed ID: 29303368
[TBL] [Abstract] [Full Text] [Related]
5. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
[TBL] [Abstract] [Full Text] [Related]
6. PLCB4 copy gain and PLCß4 overexpression in primary gastrointestinal stromal tumors: Integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free survival.
Li CF; Liu TT; Chuang IC; Chen YY; Fang FM; Chan TC; Li WS; Huang HY
Oncotarget; 2017 Mar; 8(12):19997-20010. PubMed ID: 28212550
[TBL] [Abstract] [Full Text] [Related]
7. bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.
Ramos F; Robledo C; Izquierdo-García FM; Suárez-Vilela D; Benito R; Fuertes M; Insunza A; Barragán E; Del Rey M; García-Ruiz de Morales JM; Tormo M; Salido E; Zamora L; Pedro C; Sánchez-Del-Real J; Díez-Campelo M; Del Cañizo C; Sanz GF; Hernández-Rivas JM;
Oncotarget; 2016 May; 7(21):30492-503. PubMed ID: 27127180
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Subtypes of KIT/pdgfra Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
[TBL] [Abstract] [Full Text] [Related]
9. Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST.
Wozniak A; Rutkowski P; Schöffski P; Ray-Coquard I; Hostein I; Schildhaus HU; Le Cesne A; Bylina E; Limon J; Blay JY; Siedlecki JA; Wardelmann E; Sciot R; Coindre JM; Debiec-Rychter M
Clin Cancer Res; 2014 Dec; 20(23):6105-16. PubMed ID: 25294914
[TBL] [Abstract] [Full Text] [Related]
10. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract] [Full Text] [Related]
11. [The hematological malignancies related to primary hypereosinophilia and their diagnostics].
Skonieczka K; Matiakowska K; Haus O
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1530-7. PubMed ID: 25834096
[TBL] [Abstract] [Full Text] [Related]
12. [Comprehensive analysis of genomic detection for a patient with myelodysplastic syndrome].
Luo JX; Ai C; Huang YS; Wang HW; Hu CM; Zhao WW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1501-6. PubMed ID: 24370037
[TBL] [Abstract] [Full Text] [Related]
13. Clinical utility of the new American Joint Committee on cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract] [Full Text] [Related]
14. Frequent deletion of CDKN2A and recurrent coamplification of KIT, pdgfra, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study.
Niini T; López-Guerrero JA; Ninomiya S; Guled M; Hattinger CM; Michelacci F; Böhling T; Llombart-Bosch A; Picci P; Serra M; Knuutila S
Genes Chromosomes Cancer; 2010 Feb; 49(2):132-43. PubMed ID: 19862822
[TBL] [Abstract] [Full Text] [Related]
15. Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-pdgfra correlates.
Tefferi A; Levine RL; Lim KH; Abdel-Wahab O; Lasho TL; Patel J; Finke CM; Mullally A; Li CY; Pardanani A; Gilliland DG
Leukemia; 2009 May; 23(5):900-4. PubMed ID: 19262599
[TBL] [Abstract] [Full Text] [Related]
16. Genetic aberrations of gastrointestinal stromal tumors.
Yang J; Du X; Lazar AJ; Pollock R; Hunt K; Chen K; Hao X; Trent J; Zhang W
Cancer; 2008 Oct; 113(7):1532-43. PubMed ID: 18671247
[TBL] [Abstract] [Full Text] [Related]
17. [Soft tissue sarcomas: update on molecular data].
Bui Nguyen Binh M; Collin F; Coindre JM
Cancer Radiother; 2006; 10(1-2):15-21. PubMed ID: 16442827
[TBL] [Abstract] [Full Text] [Related]
